The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients

Poulsen, Mikael KÆr; Henriksen, Jan Erik; Hother-Nielsen, Ole; Beck-Nielsen, Henning; Poulsen, Mikael Kjaer
December 2003
Diabetes Care;Dec2003, Vol. 26 Issue 12, p3273
Academic Journal
journal article
Objective: Type 2 diabetes is caused by reduced insulin secretion and insulin resistance in skeletal muscle and liver. We tested the combination therapy with insulin aspart, rosiglitazone, and metformin with the purpose of treating all three defects in order to test the hypothesis that this "triple therapy" will normalize glucose metabolism.Research Design and Methods: Sixteen obese type 2 diabetic outpatients on human NPH or MIX (regular + NPH insulin) insulin twice daily were randomized to either triple therapy, i.e., insulin aspart (a rapid-acting insulin analog) at meals, metformin (which improves hepatic insulin sensitivity), and rosiglitazone (which improves peripheral insulin sensitivity), or to continue their NPH or MIX insulin twice daily for 6 months. Insulin doses were adjusted in both groups based on algorithms. HbA(1c), insulin dose, hypoglycemic episodes, insulin sensitivity (clamp), hepatic glucose production (tracer), and diurnal profiles of plasma glucose and insulin were used in evaluating treatment.Results: In the triple therapy group, HbA(1c) declined from 8.8 to 6.8% (P < 0.01) without inducing severe hypoglycemic events. Postprandial hyperglycemia was generally avoided, and the diurnal profile of serum insulin showed fast and high peaks without any need to increase insulin dose. In the control group, the insulin dose was increased by 50%, but nevertheless both HbA(1c) and 24-h blood glucose profiles remained unchanged. Insulin sensitivity improved in both skeletal muscle and the liver in the triple therapy group, whereas no change was observed in the control group.Conclusions: We conclude that treatment of the three major pathophysiological defects in type 2 diabetic subjects by triple therapy significantly improved glucose metabolism in obese type 2 diabetic subjects.


Related Articles

  • Metformin Use with Contraindications in Diabetic Type-2 Patients. Najim, Hafsa S.; Sulaiman, Syed A.; Khan, Tahir M. // HealthMed;Dec2010, Vol. 4 Issue 4, p759 

    No abstract available.

  • Predictors of Long-Term Diabetes Remission After Metabolic Surgery. Lee, Ming; Lee, Wei-Jei; Chong, Keong; Chen, Jung-Chien; Ser, Kong-Han; Lee, Yi-Chih; Chen, Shu-Chun // Journal of Gastrointestinal Surgery;Jun2015, Vol. 19 Issue 6, p1015 

    Background Data: Bariatric/metabolic surgery has been proposed for the treatment of inadequately controlled type 2 diabetes mellitus (T2DM) in obese patients. However, prediction on successful long-term remission of T2DM after metabolic surgery has not been clearly studied. Our objectives were...

  • Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction. Lebovitz, Harold E.; Kreider, Margaret; Freed, Martin I. // Diabetes Care;May2002, Vol. 25 Issue 5, p815 

    Objective: Troglitazone treatment has been associated with idiosyncratic hepatic reaction leading to hepatic failure and death in some patients. This raises questions regarding whether all thiazolidinediones or peroxisomal proliferator-activated receptor-gamma (PPAR-gamma) agonists...

  • Erratum to: Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes. Ortega, Francisco; Mercader, Josep; Moreno-Navarrete, José; Sabater, Mónica; Pueyo, Neus; Valdés, Sergio; Ruiz, Bartomeu; Luche, Elodie; Serino, Matteo; Naon, Deborah; Ricart, Wifredo; Botas, Patricia; Delgado, Elias; Burcelin, Remy; Frühbeck, Gema; Bosch, Fatima; Mingrone, Gertrude; Zorzano, Antonio; Fernández-Real, José // Journal of Molecular Medicine;Apr2013, Vol. 91 Issue 4, p535 

    A correction to the article "Targeting the Association of Calgranulin B (S100A9) With Insulin Resistance and Type 2 Diabetes" that was published in the March 8, 2013 issue is presented.

  • Homeostasis Model Assessment as a Clinical Index of Insulin Resistance in Type 2 Diabetic Patients Treated With Sulfonylureas. Emoto, Masanori; Nishizawa, Yoshiki; Maekawa, Kiyoshi; Hiura, Yoshikazu; Kanda, Hiroyuki; Kawagishi, Takahiko; Shoji, Tetsuo; Okuno, Yasuhisa; Morii, Hirotoshi // Diabetes Care;May99, Vol. 22 Issue 5, p818 

    Presents information on a study which investigated whether homeostasis model assessment is associated with the insulin euglycemic-hyperinsulinemic clamp in a restrospective analysis in type two diabetic patients treated with sulfonylureas. Research design and methods; Results; Conclusions.

  • Treating Type 2 Diabetes Mellitus: A Growing Epidemic. Weinstock, Ruth S. // Mayo Clinic Proceedings;Apr2003, Vol. 78 Issue 4, p411 

    Editorial. Introduces articles published in the April 2003 issue of 'Mayo Clinic Proceedings' journal. Treatment of type-2 diabetes mellitus. Prevalence; Importance of early diagnosis for the initiation of aggressive treatment to prevent complications; Glycemic control; Insulin resistance.

  • Bariatric surgery can 'cure' diabetes.  // Pulse;Oct2013, p15 

    The article reports on the results of a new study which show that obese patients with type 2 diabetes who have undergo bariatric surgery remained cured six years later after the surgery.

  • Archives of Surgery: Study compares sleeve gastrectomy with medical treatment in obese patients with type 2 diabetes.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article discusses a study published online by "Archives of Surgery," a JAMA Network publication, comparing a bariatric surgical procedure with conventional medical treatment in morbidly obese patients with type 2 diabetes mellitus.

  • Cinnamon: New Applications for An Old Spice. Hawkins, Ernest B. // Natural Pharmacy;Aug2004, Vol. 8 Issue 4, p12 

    Discusses the potential of cinnamon to help the response to insulin in type 2 diabetes. Role of cinnamon in Traditional Chinese Medicine; Regulation of blood sugar levels; Use of cinnamon oil to treat oral candidiasis in patients with acquired immune deficiency syndrome.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics